BioSpace News Archive

Nemaura Announces Positive Results for its SugarBEAT European Clinical Program

The summary results were taken from a 25 patient cohort of the previously reported European three-stage 75 patient Clinical study, consisting of 80% Type 1 and 20% Type 2 Diabetics.

January 31, 2018
·
4 min read
Policy

Sientra Provides Update on FDA Review of U.S. Manufacturing Facility

The Company believes that the information requested by the FDA related to this third and final outstanding submission can be addressed quickly and is working closely with the FDA to resolve these matters in a timely manner.

January 31, 2018
·
5 min read
Biotech Bay

iHear Medical Announces FSA Eligibility for the First and Only FDA-Cleared Home Hearing Screener

Offering FSA reimbursement eligibility furthers iHEAR’s mission to provide consumers with affordable and accessible hearing solutions.

January 31, 2018
·
3 min read
Drug Development

A new Publication Confirms AZtherapies’s Innovative Drug Combination Approach to Address the Neuroinflammation Response Via Neuro-Immunology and Amyloid Beta Accumulation Associated With Neurodegeneration and Alzheimer’s Disease.

The lead product candidate, a combination multi-faceted treatment using two re-engineered drugs, cromolyn and ibuprofen, ALZT-OP1, is being studied in a Phase 3 Early Alzheimer’s clinical trial, the COGNITE trial.

January 31, 2018
·
3 min read
Eurofarma Group Release: Unprecedented Project in Brazilian Industry Has an Investment of R$ 8.4 Million

Embrapii will finance R$ 1.8 million per company with non-refundable resources, that is, without the need to refund the amount.

January 31, 2018
·
6 min read
The Next Evolution in Radiotherapy Systems is Here; RADiant by Xstrahl

Xstrahl, the leader in X-Ray Technology for treatment of Superficial Skin conditions is pleased to offer the new RADiant therapy system to Physician’s in America.

January 31, 2018
·
2 min read
Deals

QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing

The system enables scalable Sample to Insight processing of up to 48 molecular targets simultaneously to diagnose syndromes such as serious respiratory or gastrointestinal infections, as well as for use in oncology.

January 31, 2018
·
1 min read
Pharm Country

Novartis Announces NEJM Publication of Updated Analysis From ELIANA Trial Showing Longer-Term Durable Remissions With Kymriah in Children, Young Adults With r/r ALL

New data include longer-term follow-up and efficacy in 75 infused patients, analysis of expansion and persistence of Kymriah, and longer-term safety.

January 31, 2018
·
14 min read
Business

Taro to Announce Third Quarter Results on February 7, 2018

Taro Pharmaceutical Industries Ltd. announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7, 2018.

January 31, 2018
·
1 min read
Business

Owens & Minor Previews 2017 Preliminary Financial Results

Owens & Minor expects that net income per diluted share will be in a range $1.17 to $1.20 for the year ended December 31, 2017.

January 31, 2018
·
11 min read